Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
about
Chronic Lyme disease: a reviewAntibiotic treatment of animals infected with Borrelia burgdorferiDecorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in miceSpirochete antigens persist near cartilage after murine Lyme borreliosis therapyIneffectiveness of tigecycline against persistent Borrelia burgdorferiRelevance of chronic lyme disease to family medicine as a complex multidimensional chronic disease construct: a systematic reviewLyme disease: the next decade.Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages.Persistence of Borrelia burgdorferi following antibiotic treatment in miceReview of evidence for immune evasion and persistent infection in Lyme disease.Lyme arthritis: current concepts and a change in paradigm.Borreliosis: recent research, diagnosis, and management.Psychiatric comorbidity and other psychological factors in patients with "chronic Lyme disease".Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice.Diet-Induced Obesity Does Not Alter Tigecycline Treatment Efficacy in Murine Lyme Disease.Lyme disease: a turning point.Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice.The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic.
P2860
Q22252200-1700EC4F-EA04-49E8-90DF-38F4A9BB4A39Q24650857-56D87DB3-1CE5-408C-A89C-4847DA607EB9Q27310842-542218D2-B29F-4493-9B8F-9202CADEFCBCQ30519448-16E5389B-70F7-4699-B2EF-B6C4D38261CDQ33613691-A2376000-E3FC-4CF3-AF5F-F8E816DC7D4EQ34650391-6E2C4AAD-A4C1-4D1A-99FD-CEAF6DD279F3Q35026635-CC16E27A-AA89-411B-8CDE-828BD9C0BAF1Q36483556-0DF2FD26-3681-405F-A54F-0286CD5C5399Q36593814-5FFE37BD-90DB-442A-9ABF-9E97069BE081Q36797128-147C6602-1A57-4170-A439-294BEF235770Q37001131-EEA3FF6D-1A62-434C-A848-DE292031233AQ37157689-0E3DC0A9-E388-426C-9652-4C3304BE69B4Q37362241-3B8EF933-F0CE-4B6E-9765-5FB59E37EE08Q37510608-83C94975-10C5-4FE8-838F-4385A3144ECEQ37662663-B93B21CE-F65B-4FDD-8FC6-D3914050FF76Q45001149-8134AEE7-2563-4733-805D-D908C1D5FB0CQ47372972-7294D926-CC04-4C7C-A946-3CFD2A658D2BQ50041916-23153043-159B-4EF9-8081-F13B9BC71E23
P2860
Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Anti-tumor necrosis factor-alp ...... xone treatment in C3H/He mice.
@en
Anti-tumor necrosis factor-alp ...... xone treatment in C3H/He mice.
@nl
type
label
Anti-tumor necrosis factor-alp ...... xone treatment in C3H/He mice.
@en
Anti-tumor necrosis factor-alp ...... xone treatment in C3H/He mice.
@nl
prefLabel
Anti-tumor necrosis factor-alp ...... xone treatment in C3H/He mice.
@en
Anti-tumor necrosis factor-alp ...... xone treatment in C3H/He mice.
@nl
P2093
P356
P1476
Anti-tumor necrosis factor-alp ...... xone treatment in C3H/He mice.
@en
P2093
Heta Yrjänäinen
Jarmo Oksi
Kaija Hartiala
Matti K Viljanen
Xiao-yu R Song
P304
P356
10.1086/513873
P407
P577
2007-04-06T00:00:00Z